Cliff Asness’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Cliff Asness’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-32,757	Closed	-$491K	–	2347
2016 Q2	$491K	Buy	32,757 +14,721	+82%	+$189K	﹤0.01%	1888
2016 Q1	$219K	Buy	18,036 +2,446	+16%	+$34.3K	﹤0.01%	2091
2015 Q4	$248K	Buy	+15,590	New	+$245K	﹤0.01%	2085
2015 Q3	–	Sell	-20,664	Closed	-$502K	–	2340
2015 Q2	$502K	Sell	20,664 -2,836	-12%	-$67.9K	﹤0.01%	1785
2015 Q1	$546K	Buy	23,500 +10,500	+81%	+$278K	﹤0.01%	1670
2014 Q4	$326K	Buy	+13,000	New	+$381K	﹤0.01%	2167
2013 Q4	–	Sell	-19,766	Closed	-$403K	–	2654
2013 Q3	$403K	Buy	+19,766	New	+$440K	﹤0.01%	2078

Cliff Asness's SGNT Position: Q3 2016 in Review

Cliff Asness sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 32,757 shares — an estimated $491K sold.

Cliff Asness first reported a position in SGNT in Q3 2013 and held it in 7 quarters. The position peaked at $546K in Q1 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Cliff Asness reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Cliff Asness sold 32,757 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $491K.
Cliff Asness first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 7 quarters.
Cliff Asness's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $546K in Q1 2015.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on AQR Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.